Skip to content

Metamemory intervention in stroke patients: long-term effects on social participation and quality of life

Metamemory intervention in stroke patients: long-term effects on social participation and quality of life - Metamemory intervention in stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31498
Enrollment
200
Registered
2008-04-10
Start date
2008-04-11
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular accident Stroke

Interventions

The intervention consists of 10 meetings of an hour, twice a week. The experimental group is based on a valid method for healthy subjects to improve MSE through topics as depression, coping and moti

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: First and only stroke A minimum of 18 months post onset Between 18 and 80 years of age Capable to handle additional burden of care Patients have to report memory complaints independent living

Exclusion criteria

Exclusion criteria: Progressive neurological disorders Insufficient understanding of the Dutch language Drug or alcohol abuse Subarachnoidal haemmorhage, subdural haematoma

Design outcomes

Primary

MeasureTime frame
Primairily, the effect of MSE on social participation and quality of life will be measured using the SF-12, EQ 5D, IPA and WhoQol. MSE will be measured using the MIA. Social participation and quality of life are expected to improve due to the experimental MSE training.

Secondary

MeasureTime frame
Secondly, the effect of an increase in MSE social participation and quality of life on memory performance and coping style will be investigated. Memory performance will be measured using the 15 word test and the two story test from the RBMT. Coping will be measured using the assimilation-accommodation coping scale. Furthermore, usage of care will be measured in order to gain insight in the relation between MSE and the use of care long term after stroke.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)